<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Strawman Blog</provider_name><provider_url>https://strawman.com/blog</provider_url><author_name>Claude Walker</author_name><author_url>https://strawman.com/blog/author/claude-walker/</author_url><title>Nanosonics (ASXNAN) First Half Results - Strawman Blog</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="udw3ArDU6g"&gt;&lt;a href="https://strawman.com/blog/nanosonics-asxnan-first-half-results/"&gt;Nanosonics (ASXNAN) First Half Results&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://strawman.com/blog/nanosonics-asxnan-first-half-results/embed/#?secret=udw3ArDU6g" width="600" height="338" title="&#x201C;Nanosonics (ASXNAN) First Half Results&#x201D; &#x2014; Strawman Blog" data-secret="udw3ArDU6g" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://strawman.com/blog/wp-includes/js/wp-embed.min.js
/* ]]&gt; */
&lt;/script&gt;
</html><thumbnail_url>https://strawman.com/blog/wp-content/uploads/2020/02/trophon-technician02.jpg</thumbnail_url><thumbnail_width>554</thumbnail_width><thumbnail_height>286</thumbnail_height><description>Infection control company Nanosonics (ASX: NAN) today released its first half results for the 2020 Financial Year. Nanosonics sells the Trophon EPR device for disinfecting ultrasound probes, as well as the consumable capsules required for each disinfection cycle. This can be thought of as a razor + blade business model. The bad news was that profit before tax was down [&hellip;]</description></oembed>
